ASO Author Reflections: Survival Benefit of Adjuvant Chemoradiotherapy for Gallbladder Cancer: The Role of Radiation Therapy Revisited

Byoung Hyuck Kim¹, Eui Kyu Chie^{2

3}, Kyubo Kim⁴

Affiliations

¹ Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea.
² Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea. ekchie93@snu.ac.kr.
³ Institute of Radiation Medicine, Medical Research Center, Seoul National University, Seoul, Korea. ekchie93@snu.ac.kr.
⁴ Department of Radiation Oncology, Ewha Womans University College of Medicine, Seoul, Korea. kyubokim.ro@gmail.com.

Comment

Byoung Hyuck Kim et al. Ann Surg Oncol. 2018 Dec.

. 2018 Dec;25(Suppl 3):788-789.

doi: 10.1245/s10434-018-6894-7. Epub 2018 Oct 15.

Byoung Hyuck Kim¹, Eui Kyu Chie^{2

3}, Kyubo Kim⁴

¹ Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea.
² Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea. ekchie93@snu.ac.kr.
³ Institute of Radiation Medicine, Medical Research Center, Seoul National University, Seoul, Korea. ekchie93@snu.ac.kr.
⁴ Department of Radiation Oncology, Ewha Womans University College of Medicine, Seoul, Korea. kyubokim.ro@gmail.com.

No abstract available

Comment on

Adjuvant Chemoradiotherapy is Associated with Improved Survival for Patients with Resected Gallbladder Carcinoma: A Systematic Review and Meta-analysis.
Kim BH, Kwon J, Chie EK, Kim K, Kim YH, Seo DW, Narang AK, Herman JM. Kim BH, et al. Ann Surg Oncol. 2018 Jan;25(1):255-264. doi: 10.1245/s10434-017-6139-1. Epub 2017 Oct 27. Ann Surg Oncol. 2018. PMID: 29079926